Meir Orbach

1 week ago | calcalistech.com | Meir Orbach

Israeli-founded startup’s FDA-cleared test delivers PCR results in 30 minutes. 14:36, 19.06.25 TAGS:FundingVisbyHealthtechVisby Medical, founded by Israeli professor Adam de la Zerda, has raised approximately $55 million, with the potential to reach $65 million, in a funding round led by Catalio Capital Management. Existing investors, including ND Capital, Cedars-Sinai Medical Center, Blue Water Life Science Advisors, Pitango Ventures, and John Doerr, also participated in the round.

1 week ago | calcalist.co.il | Meir Orbach

Coralogix raises $115 million Series E at over $1 billion valuationThe round, which takes the Israeli startup's total funding to $350 million to date, was completed before the start of the war with Iran. Israeli company Coralogix, which develops a platform for monitoring, securing, and managing software and AI systems, has raised $115 million in a Series E funding round, bringing its total funding to $350 million to date.

1 week ago | calcalistech.com | Meir Orbach

The all-Israeli deal, signed amid the war with Iran, is estimated at $10–20 million. 17:24, 17.06.25 TAGS:FintechTipaltiAcquisitionStatementIsraeli fintech unicorn Tipalti, which develops a platform for financial automation, is acquiring Israeli startup Statement, a company that specializes in AI-based cash flow management solutions. The acquisition agreement was signed on Tuesday, and significantly enhances Tipalti’s capabilities in the financial management space.

1 week ago | calcalistech.com | Meir Orbach

The round, which takes the Israeli startup's total funding to $350 million to date, was completed before the start of the war with Iran. 15:00, 17.06.25 TAGS:DevOpsCoralogixFundingIsraeli company Coralogix, which develops a platform for monitoring, securing, and managing software and AI systems, has raised $115 million in a Series E funding round, bringing its total funding to $350 million to date.

1 week ago | calcalist.co.il | Meir Orbach

Like much of the country, Israeli high-tech was caught by surprise with the sudden escalation of war with Iran. But according to Shahar Tzafrir, Managing Partner at TLV Partners, one of Israel’s leading early-stage venture capital funds, this time the sector is facing the crisis without panic - unlike during the COVID-19 pandemic or following the October 7 attacks. "Everything is still very fresh, we woke up to a major surprise before we even fully understood what was happening," said Tzafrir.